Last reviewed · How we verify
NRT-S
At a glance
| Generic name | NRT-S |
|---|---|
| Also known as | NRT sample |
| Sponsor | The University of Hong Kong |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Depression
- Anxiety
- Increased psychiatric symptoms
- skin irritation at the patch site
- Headache
- Nausea / Upset stomach
- Cold symptoms
- Vivid dreams
Key clinical trials
- iCanQuit Smoking Cessation Among Hispanic Adults (PHASE3)
- Quit-Smoking Study for Native Hawaiians (NA)
- The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up (NA)
- Smoking Cessation Programme in Workplaces in Hong Kong (Phase ⅤII) (NA)
- Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial (NA)
- Smoking Cessation Programme in Workplaces in Hong Kong (Phase Ⅴ) (NA)
- Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) (NA)
- Interactive Communication Technologies and Nicotine Replacement Therapy Sampling for Smokers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NRT-S CI brief — competitive landscape report
- NRT-S updates RSS · CI watch RSS
- The University of Hong Kong portfolio CI